Submit your abstract for SDRI 2017!
We're pleased to announce that the inaugural SDRI conference will take place in Brisbane, Australia from 3–5 April 2017. Submit your abstract today!
For decades, Asia Pacific countries have played a leading worldwide role in research in antimicrobial drug discovery, molecular diagnosis and infectious diseases.
SDRI 2017 is a multi-disciplinary scientific conference for the Asia Pacific region focused on Solutions for Drug-Resistant Infections. This inaugural conference theme is New Drugs for Drug-Resistant Infections. The conference will take place at the Brisbane Convention and Exhibition Centre in Australia from 3–5 April, 2017.
The program is expected to attract 400 international participants and will provide a fantastic forum for researchers and industry representatives working in the space of microbiology, virology, parasitology, genomics, pharmacology and medicinal chemistry, to network and discuss new ways to solve the global challenge of drug-resistant infections. Our goal for SDRI 2017 is to lead a concerted discussion to set three priorities and guide research efforts towards global solutions for drug resistance research.
Submit your oral abstract today
Abstract submission deadline: 14 October 2016
With a host of world-class speakers and a sunny Australia location, SDRI 2017 promises to be an inspiring conference – and you can be part of it.
Don’t miss out on your chance to showcase your latest research alongside speakers such as:
Over the last six years England’s Chief Medical Officer, Dame Sally Davies, has been working tirelessly on awareness and action on AMR, with the support of many other governments, organisations and programmes. Join Dame Sally and CDDEP Health Economist and AMR expert Professor Ramanan Laminarayan next April in Brisbane for SDRI 2017 conference.
Professor Sally Davies
Chief Medical Officer (CMO) for England
Professor Ramanan Laxminarayan
Public Health Foundation of India
Dr Manica Balasegaram
Dr Kade Roberts
SDRI 2017 Session themes
- Antimicrobial resistance
- Antimicrobial drug discovery
- Improvements to existing anti-infective agents and repurposing
- New drug targets
- Alternate therapies
- Vector control and vaccines
- International models and funding
- Navigating the pipeline
- Panel - top 3 priorities to guide AMR research
Registration is now open
We look forward to welcoming you to Queensland in 2017.
Professor Matthew Cooper
Co-Chair SDRI 2017
Director of the Centre for Superbug Solutions
Institute for Molecular Bioscience
The University of Queensland
Professor Jian Li
Co-Chair SDRI 2017
Monash Biomedicine Discovery Institute
submission deadline - 14 October 2016
Earlybird deadline - 9 December 2016
Conference dates - 3 - 5 April 2017